| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 12:38:24 UTC |
|---|
| Update Date | 2022-09-22 17:45:02 UTC |
|---|
| HMDB ID | HMDB0253783 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Ketanserin |
|---|
| Description | Ketanserin belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group. Ketanserin is a very strong basic compound (based on its pKa). It was discovered at Janssen Pharmaceutica in 1980. It has been used in cardiac surgery. The same research team found no significant correlation with age in their homogenate binding study. It has also been found to block the vesicular monoamine transporter 2 (VMAT2). With tritium (3H) radioactively labeled ketanserin is used as a radioligand for serotonin 5-HT2 receptors, e.g. in receptor binding assays and autoradiography. Ketanserin is a high-affinity non-selective antagonist of 5-HT2 receptors in rodents, with Ki values of 2–3 nM for the 5-HT2A receptor and 28 nM for the 5-HT2C receptor). However, due to the significant adverse effect burden, the authors concluded that ketanserin's utility for this indication is likely unbeneficial. Ketanserin (INN, USAN, BAN) (brand name Sufrexal; former developmental code name R41468) is a drug used clinically as an antihypertensive agent and in scientific research to study the serotonin system; specifically, the 5-HT2 receptor family. This compound has been identified in human blood as reported by (PMID: 31557052 ). Ketanserin is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Ketanserin is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | FC1=CC=C(C=C1)C(=O)C1CCN(CCN2C(=O)NC3=CC=CC=C3C2=O)CC1 InChI=1S/C22H22FN3O3/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29) |
|---|
| Synonyms | | Value | Source |
|---|
| 3-[2-[4-(4-Fluorobenzoyl)-1-piperidyl]ethyl]-1H-quinazoline-2,4-dione | ChEBI | | Ketanserina | ChEBI | | Ketanserine | ChEBI | | Ketanserinum | ChEBI | | 3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione | MeSH |
|
|---|
| Chemical Formula | C22H22FN3O3 |
|---|
| Average Molecular Weight | 395.434 |
|---|
| Monoisotopic Molecular Weight | 395.164519743 |
|---|
| IUPAC Name | 3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-1,2,3,4-tetrahydroquinazoline-2,4-dione |
|---|
| Traditional Name | ketanserin |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | FC1=CC=C(C=C1)C(=O)C1CCN(CCN2C(=O)NC3=CC=CC=C3C2=O)CC1 |
|---|
| InChI Identifier | InChI=1S/C22H22FN3O3/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29) |
|---|
| InChI Key | FPCCSQOGAWCVBH-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbonyl compounds |
|---|
| Direct Parent | Alkyl-phenylketones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alkyl-phenylketone
- Diazanaphthalene
- Quinazoline
- Benzoyl
- Aryl alkyl ketone
- Fluorobenzene
- Halobenzene
- Hydroxypyrimidine
- Pyrimidone
- Aryl fluoride
- Aryl halide
- Monocyclic benzene moiety
- Gamma-aminoketone
- Piperidine
- Pyrimidine
- Benzenoid
- Heteroaromatic compound
- Lactam
- Tertiary amine
- Tertiary aliphatic amine
- Azacycle
- Organoheterocyclic compound
- Organic nitrogen compound
- Amine
- Organonitrogen compound
- Organofluoride
- Organohalogen compound
- Organic oxide
- Hydrocarbon derivative
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 11.0394 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.32 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1467.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 203.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 170.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 176.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 115.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 355.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 415.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 194.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 778.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 432.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1250.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 278.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 305.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 356.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 244.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 25.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Ketanserin,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)N(CCN2CCC(C(=O)C3=CC=C(F)C=C3)CC2)C(=O)C2=CC=CC=C21 | 3406.1 | Semi standard non polar | 33892256 | | Ketanserin,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)N(CCN2CCC(C(=O)C3=CC=C(F)C=C3)CC2)C(=O)C2=CC=CC=C21 | 3194.5 | Standard non polar | 33892256 | | Ketanserin,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)N(CCN2CCC(C(=O)C3=CC=C(F)C=C3)CC2)C(=O)C2=CC=CC=C21 | 4234.3 | Standard polar | 33892256 | | Ketanserin,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)N(CCN2CCC(C(=O)C3=CC=C(F)C=C3)CC2)C(=O)C2=CC=CC=C21 | 3581.8 | Semi standard non polar | 33892256 | | Ketanserin,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)N(CCN2CCC(C(=O)C3=CC=C(F)C=C3)CC2)C(=O)C2=CC=CC=C21 | 3391.8 | Standard non polar | 33892256 | | Ketanserin,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)N(CCN2CCC(C(=O)C3=CC=C(F)C=C3)CC2)C(=O)C2=CC=CC=C21 | 4254.6 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Ketanserin GC-MS (Non-derivatized) - 70eV, Positive | splash10-00di-7950000000-74fc2a746ecc54e92943 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ketanserin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketanserin 10V, Positive-QTOF | splash10-0002-0219000000-78bf9d9276e44824d54c | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketanserin 20V, Positive-QTOF | splash10-000i-0912000000-29399db0edad451149f2 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketanserin 40V, Positive-QTOF | splash10-03dl-3900000000-b1898672b4a7b2b23a5b | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketanserin 10V, Negative-QTOF | splash10-01ox-0609000000-d3c3bc35fe222b97c7c8 | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketanserin 20V, Negative-QTOF | splash10-0006-1439000000-279eefb55f3e7f2ac984 | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketanserin 40V, Negative-QTOF | splash10-0006-9820000000-8f95a266435787172658 | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketanserin 10V, Negative-QTOF | splash10-0006-0009000000-37133899d8dc7c385562 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketanserin 20V, Negative-QTOF | splash10-0006-0309000000-52033eafdd30495390be | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketanserin 40V, Negative-QTOF | splash10-0297-5961000000-38afc0786a1f7ed525ba | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketanserin 10V, Positive-QTOF | splash10-0002-0009000000-0a62af1817793f2b6956 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketanserin 20V, Positive-QTOF | splash10-000i-0903000000-5980133a99d44b5b6844 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketanserin 40V, Positive-QTOF | splash10-000i-1900000000-43dc6e5f3f18c054604a | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|